Product apis-apoptosis

Home > products > apis> apoptosis

Catalog	name	Description	price
R-R-1640	Lucidenic acid B CAS No.95311-95-8	Lucidenic acid B/CAS No.95311-95-8 is a natural compound isolated from Ganoderma lucidum, induces apoptosis of cancer cells, and causes the activation of caspase-9 and caspase-3, and cleavage of PARP. Lucidenic acid B does not affect the cell cycle profile, or the number of necrotic cells.	price>
R-R-1641	Ajoene CAS No.92285-01-3	Ajoene/CAS No.92285-01-3, a garlic-derived compound, is an antithrombotic and antifungal agent. Ajoene inhibits proliferation and induces apoptosis of human leukaemia CD34-negative cells including HL-60, U937, HEL and OCIM-I. Anticancer activities.	price>
R-R-1642	Reveromycin A CAS No.134615-37-5	Reveromycin A/CAS No.134615-37-5, a benzoquinoid antibiotic isolated from the genus Streptomyces, is a selective inhibitor of protein synthesis in eukaryotic cells. Reveromycin A inhibits bone resorption by inducing apoptosis specifically in osteoclasts. Reveromycin A has antiproliferative activity against tumor cell lines and antifungal activity.	price>
R-R-1643	3-Dehydrotrametenolic acid CAS No.29220-16-4	3-Dehydrotrametenolic acid/CAS No.29220-16-4, isolated from the sclerotium of Poria cocos, is a lactate dehydrogenase (LDH) inhibitor. 3-Dehydrotrametenolic acid promotes adipocyte differentiation in vitro and acts as an insulin sensitizer in vivo. 3-Dehydrotrametenolic acid induces apoptosis and has anticancer activity.	price>
R-R-1644	Ceramide C6-d7 CAS No.2692624-22-7	Ceramide C6-d7/CAS No.2692624-22-7 is the deuterium labeled Ceramide C6. Ceramide C6, a Ceramide pathway activator, is an exogenous short-chain ceramide which can induce apoptosis of multiple cancer cells.	price>
R-R-1645	C24:1-Ceramide CAS No.54164-50-0	C24:1-Ceramide/CAS No.54164-50-0 is one of the most abundant naturally occurring ceramide. Ceramides regulates many diverse biological activities, such as cell apoptosis, cell differentiation, proliferation of smooth muscle cells, and inhibition of the mitochondrial respiratory chain.	price>
R-R-1646	Droloxifene CAS No.82413-20-5	Droloxifene/CAS No.82413-20-5, a Tamoxifen derivative, is an orally active and selective estrogen receptor modulator. Droloxifene shows antiestrogenic and anti-implantation effects. Droloxifene induces p53 expression and apoptosis in MCF-7 cells. Droloxifene prevents bone loss in ovariectomized rats .	price>
R-R-1647	Odoroside A CAS No.12738-19-1	Odoroside A/CAS No.12738-19-1 is an active ingredient extracted from the leaves of Nerium oleander Linn. Odoroside A has anti-cancer activity. Odoroside A could induce apoptosis and cell cycle arrest through ROS/p53 signaling pathway, leading to the tumor cell death.	price>
R-R-1648	Euphorbia Factor L2 CAS No.218916-51-9	Euphorbia factor L2/CAS No.218916-51-9, a lathyrane diterpenoid isolated from caper euphorbia seed (the seeds of Euphorbia lathyris L.), has been traditionally applied to treat cancer. Euphorbia factor L2 shows potent cytotoxicity and induces apoptosis via a mitochondrial pathway.	price>
R-R-1649	Dehydroleucodine CAS No.36150-07-9	Dehydroleucodine/CAS No.36150-07-9 is a sesquiterpene lactone isolated from Artemisia douglasiana. Dehydroleucodine is a mast cell stabilizer that inhibits tmast cell degranulation induced by compound 48/80. Dehydroleucodine inudces cells apoptosis, and has gastric ulcer inhibition and antileukemic effects.	price>

...